丽珠医药9月26日斥资499.79万元回购13.08万股A股

Core Viewpoint - Lijun Pharmaceutical (01513) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Summary by Category Company Actions - The company plans to repurchase 130,800 A-shares at a total cost of RMB 4.9979 million [1] - The buyback price range is set between RMB 37.99 and RMB 38.46 per share [1] Financial Implications - The total expenditure for the buyback reflects the company's strategy to enhance shareholder value [1]